openPR Logo
Press release

The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

12-04-2020 05:31 AM CET | Health & Medicine

Press release from: Roots Analysis

The novel vaccine delivery devices market is estimated to be

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient

Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”.

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html

The report features an extensive study of the current landscape and the likely future opportunities associated with novel vaccine delivery devices, over the next 10-12 years. Amongst other elements, the report includes:
A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers engaged in the development of novel vaccine delivery devices.
A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power and key product specifications.
An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of parameters.
A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future.
Elaborate profiles of prominent product developers engaged in the novel vaccine delivery devices domain (shortlisted on the basis of the number of pipeline products).
An analysis of the partnerships that have been established in this domain, in the recent past.
A discussion on important, industry-specific trends, key market drivers and challenges, under a comprehensive SWOT framework.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Global Novel Vaccine Delivery Devices (By Value)
Type of Device
Electroporation-based Needle Free Injection Systems
Oral Delivery Systems
Nasal Delivery Systems
Jet Injectors
Microneedle Patches
Microinjectors

Route of Administration
Oral
Intramuscular
Intranasal
Intradermal
Subcutaneous

Type of Vaccines
Bivalent Oral Polio Vaccine
BCG Vaccine
DTP-HepB-Hib Vaccine
Pneumococcal Conjugate Vaccine
Influenza Vaccine
Measles Vaccine
Tetanus-Diphtheria Vaccine
Others

Key Geographical Region
North America
Europe
Asia Pacific
Rest of the World

Key companies covered in the report
3M
Becton Dickinson
Consort Medical
D’Antonio Consultants International
Enesi Pharma
Ichor Medical
Iconovo
Inovio Pharmaceuticals
PharmaJet
Union Medico

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email sales@rootsanalysis.com

You may also be interested in the following titles:
1. Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
2. Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030
3. Large Volume Wearable Injectors Market (4th Edition), 2018-2030
4. Global Autoinjectors Market (2nd Edition), 2018-2030

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The novel vaccine delivery devices market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis here

News-ID: 2202209 • Views:

More Releases from Roots Analysis

Microbial Fermentation CMO Market Set to Triple by 2035, Fueled by Biologics Boom
Microbial Fermentation CMO Market Set to Triple by 2035, Fueled by Biologics Boo …
The microbial fermentation contract manufacturing organization (CMO) market is on an exciting growth trajectory, projected to soar from USD 3.6 billion in 2024 to over USD 9.1 billion by 2035. This robust expansion, at a compound annual growth rate (CAGR) of 8.7%, reflects the rising demand for biologics and the increasing trend of outsourcing microbial fermentation processes to specialized CMOs, according to a comprehensive new report by Roots Analysis. Why Microbial
Peptide Synthesis Market Set to Double by 2035, Driven by Surge in Outsourcing and High-Purity Demand
Peptide Synthesis Market Set to Double by 2035, Driven by Surge in Outsourcing a …
In a world where precision medicine is rapidly reshaping healthcare, the global peptide synthesis market is emerging as a quiet powerhouse. According to a comprehensive new report from Roots Analysis, the sector is poised to leap from a $2.8 billion valuation in 2024 to an impressive $5.1 billion by 2035, growing at a steady 5.5% compound annual growth rate (CAGR). This growth is fueled by a perfect storm of scientific
Global Needles Market Set to Surpass $14.7 Billion by 2035, Fueled by Chronic Disease Surge and Innovation
Global Needles Market Set to Surpass $14.7 Billion by 2035, Fueled by Chronic Di …
In a world where chronic diseases like diabetes, cancer, and heart conditions are on the rise, the humble needle has become an unsung hero of modern medicine. According to a new report from Roots Analysis, the global needles market is poised for remarkable growth-projected to leap from $8.1 billion in 2025 to over $14.7 billion by 2035, growing at a steady 6.1% annual clip. This surge isn't just about numbers;
ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035
ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035
In the fast-evolving world of biopharmaceuticals, the demand for precision and innovation has never been higher. Nowhere is this more evident than in the rapidly expanding market for Antibody-Drug Conjugate (ADC) contract manufacturing. According to a comprehensive new report from Roots Analysis, the global ADC contract manufacturing market is poised for remarkable growth-projected to surge from USD 1.79 billion in 2024 to over USD 6.8 billion by 2035, at a

All 5 Releases


More Releases for Vaccine

Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion
Key Tools for Innovative Vaccine Designs: Vaccine Adjuvants
The report “NORTH AMERICA VACCINE ADJUVANTS MARKET” provides the detail description of market segmentation, applications, growth, size, and outlook. The market is projected to reach USD $278 Million by 2024, at a CAGR of 11.3%. An adjuvant is an immunological agent, which modifies the effect of other agents. Adjuvants can also act as an irritant, which engages and amplifies the body immune response. Adjuvants are added to vaccines to boost the